Key Takeaways
- • UCSF Health, Kleiner Perkins, and Doerr Capital launched UCSF Health Converge, a new health AI accelerator that embeds select startup companies directly within one of the nation's leading academic health systems to co-develop and validate AI solutions in real clinical workflows.
- • The accelerator operates on an "inside-out" model, positioning founders and startups inside UCSF Health's clinical operations, technology systems, and workflows rather than requiring healthcare organizations to adopt external tools—addressing a fundamental challenge in healthcare AI deployment.
- • Healthcare AI funding has reached $18 billion in venture capital investment, signaling substantial investor appetite; this partnership model targets enterprise-grade AI solutions that meet standards for clinical excellence, safety, trustworthiness, equity, and patient-centered care at scale.
- • Success metrics focus on measurable clinical impact, including whether solutions improve patient care outcomes, integrate seamlessly into existing workflows, achieve adoption by care teams, and scale responsibly across multiple specialties and care settings within the health system.
- • Applications are open for the first cohort, with UCSF Health, Kleiner Perkins, and Doerr Capital selecting a limited number of companies annually to participate in the co-development program.
Summary
UCSF Health, Kleiner Perkins, and Doerr Capital announced UCSF Health Converge on July 15, 2026, a novel health AI accelerator designed to address persistent challenges in healthcare technology adoption. The partnership represents a strategic shift from traditional venture-backed healthcare AI development, which has attracted nearly $18 billion in venture capital investment but has struggled with implementation barriers in clinical environments. Rather than requiring health systems to retrofit external AI tools into existing operations, UCSF Health Converge inverts this model by embedding selected startup companies directly within one of the nation's leading academic health systems.
The accelerator centers on what organizers describe as an "inside-out" approach to healthcare AI development. Selected companies will work alongside UCSF Health clinicians, operators, and technology leaders within the actual workflows, technology infrastructure, and operational realities that determine whether innovations can succeed at enterprise scale. This embedded co-development structure addresses what healthcare executives identify as a critical gap: most AI solutions are built without deep understanding of the complex, highly regulated clinical environments where they must ultimately perform. According to Suresh Gunasekaran, President & CEO of UCSF Health, "Healthcare does not need more AI tools looking for a use case. It needs solutions built around the real needs of patients, care teams, and the systems responsible for delivering care."
The program will evaluate participating companies against rigorous standards including clinical excellence, safety, trustworthiness, equity, and patient-centered care. Success will be measured by tangible impact within UCSF Health's operations: whether solutions demonstrably improve patient outcomes, integrate into existing workflows without disruption, achieve adoption by care teams, and scale responsibly across multiple clinical specialties and care settings. UCSF Health recognizes that future health systems require better tools for clinical teams, enhanced patient support, and a responsible framework for deploying AI in complex, regulated environments. The accelerator will select a limited cohort of companies annually, with applications now open for the first class of participants.
The accelerator centers on what organizers describe as an "inside-out" approach to healthcare AI development. Selected companies will work alongside UCSF Health clinicians, operators, and technology leaders within the actual workflows, technology infrastructure, and operational realities that determine whether innovations can succeed at enterprise scale. This embedded co-development structure addresses what healthcare executives identify as a critical gap: most AI solutions are built without deep understanding of the complex, highly regulated clinical environments where they must ultimately perform. According to Suresh Gunasekaran, President & CEO of UCSF Health, "Healthcare does not need more AI tools looking for a use case. It needs solutions built around the real needs of patients, care teams, and the systems responsible for delivering care."
The program will evaluate participating companies against rigorous standards including clinical excellence, safety, trustworthiness, equity, and patient-centered care. Success will be measured by tangible impact within UCSF Health's operations: whether solutions demonstrably improve patient outcomes, integrate into existing workflows without disruption, achieve adoption by care teams, and scale responsibly across multiple clinical specialties and care settings. UCSF Health recognizes that future health systems require better tools for clinical teams, enhanced patient support, and a responsible framework for deploying AI in complex, regulated environments. The accelerator will select a limited cohort of companies annually, with applications now open for the first class of participants.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.